What are clopidogrel used for
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest clopidogrel is used for treating and preventing cardiovascular diseases, reducing the risk of major ischemic events, and enhancing the efficacy of certain anticancer drugs, but it may increase bleeding risks and interact with other medications.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Uses of Clopidogrel: A Comprehensive Overview
Clopidogrel for Cardiovascular Disease Prevention
Clopidogrel is primarily used as an antiplatelet medication to prevent atherosclerotic events such as myocardial infarction, ischemic stroke, and vascular death in patients with atherosclerosis. This includes those with recent stroke, myocardial infarction, or established peripheral vascular disease. The CAPRIE study demonstrated that clopidogrel significantly reduces the risk of these events compared to aspirin, particularly in patients with a history of coronary artery bypass surgery, diabetes mellitus, or those receiving lipid-lowering therapy.
Dual Antiplatelet Therapy (DAPT) in Acute Coronary Syndrome (ACS)
Clopidogrel is often used in combination with aspirin as part of dual antiplatelet therapy (DAPT) for the secondary prevention of acute coronary syndrome (ACS). The CURE trial showed that clopidogrel combined with aspirin is more effective than aspirin alone in reducing the composite outcome of death from cardiovascular causes, non-fatal myocardial infarction, or stroke in patients with non-ST-segment elevation ACS. However, this combination is associated with an increased risk of bleeding.
Clopidogrel in Stroke and Transient Ischemic Attack (TIA)
For patients with minor ischemic stroke or high-risk transient ischemic attack (TIA), clopidogrel combined with aspirin is effective for secondary prevention. The CHANCE and POINT trials found that this combination reduces the risk of major ischemic events within the first 21 days after a minor stroke or TIA, although the benefit does not extend beyond this period. Clopidogrel monotherapy is also recommended for up to 90 days following a high-risk TIA or minor stroke.
Peripheral Artery Disease (PAD)
Clopidogrel is used in patients with symptomatic peripheral artery disease (PAD) to reduce the risk of atherothrombotic events. It is often preferred over aspirin due to its better gastrointestinal tolerability and lower incidence of gastrointestinal hemorrhage.
Clopidogrel in Neurointerventional Procedures
Clopidogrel is routinely used to decrease ischemic complications during neurointerventional procedures, such as the treatment of unruptured intracranial aneurysms. Studies have shown that low-dose prasugrel, an alternative to clopidogrel, may reduce ischemic complications more effectively with an acceptable rate of hemorrhagic complications.
Clopidogrel and Cancer Treatment
Recent studies have explored the use of clopidogrel in combination with anticancer drugs. Clopidogrel has shown potential in increasing the antitumor and antimetastatic activity of certain chemotherapeutics, although it may also decrease the efficacy of others and increase treatment toxicity. This highlights the need for careful evaluation when using clopidogrel in patients undergoing chemotherapy.
Safety and Tolerability
Clopidogrel is generally well-tolerated, with a safety profile similar to aspirin. However, it is associated with a risk of bleeding, particularly when used in combination with other antiplatelet agents like aspirin or warfarin. Higher loading doses of clopidogrel increase the risk of bleeding, and clinicians must weigh these risks against the potential benefits.
Conclusion
Clopidogrel is a versatile antiplatelet medication used in various clinical settings, including the prevention of cardiovascular events, secondary prevention in ACS, stroke, and TIA, and in patients with PAD. Its combination with aspirin as part of DAPT is particularly effective in reducing ischemic events, although it comes with an increased risk of bleeding. Clopidogrel's role in cancer treatment and neurointerventional procedures further underscores its importance in clinical practice.
Sources and full results
Most relevant research papers on this topic
